A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Hepatic Impairment Compared With Matched Healthy Participants
Clinical trial NCT05753592 · COMPLETED
Trial details
- NCT number
- NCT05753592
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2023-12-14
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.